TaiwanBiotech & Genomic Medicine▲
Cell and Gene Therapy CDMO Market to Reach $57.1 Billion by 2034
The global cell and gene therapy CDMO market is projected to grow from $8.3 billion in 2025 to $57.1 billion by 2034, at a compound annual growth rate of approximately 24%, according to a report by DelveInsight. North America held the largest share in 2025, accounting for roughly 40% of the global market, driven by an expanding pipeline of cell and gene therapies and substantial investments in innovative technologies. Key companies in the market include Catalent, Minaris Advanced Therapies, SCTbio, Cellex Cell Professionals, Mycenax Biotech, MedTherapy Biotech, ENCELL, Nucelion Biotechnologies, Charles River Laboratories, Lonza Group, Thermo Fisher Scientific, and WuXi AppTec. Recent developments include Catalent expanding its agreement with Cartherics for iPSC-derived CAR-NK cell therapies in April 2026, and Lonza expanding its manufacturing agreement with Genetix Biotherapeutics for ZYNTEGLO in March 2026. The market growth is fueled by rising numbers of cell and gene therapy candidates, increasing outsourcing trends, and advancements in manufacturing technologies.
About megatrends
Biotech & Genomic Medicine › CDMO / Contract Manufacturing ▲Demand
Catalent, Inc. · Demand · Positive Catalent is a key CDMO in the growing cell and gene therapy market, with a recent expansion agreement with Cartherics.
LONN.SW · Demand · Positive Mentioned as a key company and noted for expanding manufacturing agreement for ZYNTEGLO, indicating demand growth.
4726.TWO · Demand · Positive Listed as a key company in the growing CDMO market, with market growth driven by increasing therapy candidates.
603259.CG · Demand · Positive Named as a key company in the cell and gene therapy CDMO market, which is forecast to grow significantly.
CRL · Demand · Positive Mentioned as a key company in the growing cell and gene therapy CDMO market, which is projected to grow at 24% CAGR.
TMO · Demand · Positive Listed as a key player in the expanding CDMO market, benefiting from rising outsourcing trends.